Zobrazeno 1 - 10
of 17 492
pro vyhledávání: '"tie-2"'
Autor:
Rämö JT; From the Broad Institute of MIT and Harvard (J.T.R., E.J.R.), Cambridge, Massachusetts, USA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) (J.T.R.), University of Helsinki, Helsinki, Finland; Massachusetts Eye and Ear (J.T.R., D.E., L.S., D.G.V., E.J.R.), Boston, Massachusetts, USA., Kim LA; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Stryjewski T; Tallman Eye Associates (T.S.), Lawrence, Massachusetts, USA., Shah PP; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Bejjani R; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Brodie FL; Department of Ophthalmology (F.L.B), University of San Francisco California, San Francisco, California, USA., Eliott D; Massachusetts Eye and Ear (J.T.R., D.E., L.S., D.G.V., E.J.R.), Boston, Massachusetts, USA; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Sobrin L; Massachusetts Eye and Ear (J.T.R., D.E., L.S., D.G.V., E.J.R.), Boston, Massachusetts, USA; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Vavvas DG; Massachusetts Eye and Ear (J.T.R., D.E., L.S., D.G.V., E.J.R.), Boston, Massachusetts, USA; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA., Rossin EJ; From the Broad Institute of MIT and Harvard (J.T.R., E.J.R.), Cambridge, Massachusetts, USA; Massachusetts Eye and Ear (J.T.R., D.E., L.S., D.G.V., E.J.R.), Boston, Massachusetts, USA; Department of Ophthalmology (L.A.K., P.P.S., R.B., D.E., L.S., D.G.V., E.J.R.), Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA. Electronic address: Elizabeth_rossin@meei.harvard.edu.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2025 Jan; Vol. 269, pp. 246-254. Date of Electronic Publication: 2024 Sep 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhou, Haiyan1,2 (AUTHOR) zhy818ella@163.com, Chen, Tangting3 (AUTHOR) ctt@swmu.edu.cn, Li, Yongjie1,2 (AUTHOR) sbyniso@163.com, You, Jingcan1,2 (AUTHOR) youjc15922801974@163.com, Deng, Xin1,2 (AUTHOR) xindeng1988@163.com, Chen, Ni1,2 (AUTHOR) chenniluyi@126.com, Li, Tian1,2 (AUTHOR) litianforever@163.com, Zheng, Youkun1,2 (AUTHOR) zyktmx@swmu.edu.cn, Li, Rong1,2 (AUTHOR) hubeilirong@126.com, Luo, Mao1,2 (AUTHOR) luomao20050908@swmu.edu.cn, Wu, Jianbo1,2 (AUTHOR) jbwucn@swmu.edu.cn, Wang, Liqun1,2 (AUTHOR) jbwucn@swmu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 13, p7137-N.PAG. 13p.
Autor:
Yan, Fanfan1,2,3,4 (AUTHOR), Meng, Xiaojing1,2,3,4 (AUTHOR), Cheng, Xialong1,2,3,4 (AUTHOR), Pei, Wenzhi1,2,3,4 (AUTHOR), Chen, Yuanyuan1 (AUTHOR), Chen, Long1,2,3,4 (AUTHOR), Zheng, Mingming1,2,3,4 (AUTHOR), Shi, Li1 (AUTHOR), Zhu, Cuizhen1,2,3,4 (AUTHOR) zhucuizhen88@126.com, Zhang, Xulai1,2,3,4 (AUTHOR) xulaiZhang@ahmhcentre.com
Publikováno v:
BMC Psychiatry. 7/25/2023, Vol. 23 Issue 1, p1-10. 10p. 4 Charts, 1 Graph.
Autor:
Fanfan Yan, Xiaojing Meng, Xialong Cheng, Wenzhi Pei, Yuanyuan Chen, Long Chen, Mingming Zheng, Li Shi, Cuizhen Zhu, Xulai Zhang
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Schizophrenia (SCZ) is associated with chronic low-grade inflammation, which may be involved in the underlying pathological mechanism of the disease and may influence patient prognosis. We evaluated the differences in serum cytoki
Externí odkaz:
https://doaj.org/article/399407de10eb45c7866e7eded72a8631
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li H; College of Chemistry, Fuzhou University, Fuzhou, 350116, China., Wang R; College of Chemistry, Fuzhou University, Fuzhou, 350116, China., Xu P; College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350116, China., Yuan C; College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350116, China., Huang M; College of Chemistry, Fuzhou University, Fuzhou, 350116, China; The National & Local Joint Engineering Research Center on Biopharmaceutical and Photodynamic Therapy Technologies, Fuzhou University, Fuzhou, Fujian, 350116, China. Electronic address: hmd_lab@fzu.edu.cn., Jiang L; College of Chemistry, Fuzhou University, Fuzhou, 350116, China; The National & Local Joint Engineering Research Center on Biopharmaceutical and Photodynamic Therapy Technologies, Fuzhou University, Fuzhou, Fujian, 350116, China. Electronic address: jianglg@fzu.edu.cn.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 26; Vol. 735, pp. 150484. Date of Electronic Publication: 2024 Jul 31.
Autor:
Schwakopf J; Department of Neurobiology, University of Utah, Salt Lake City, UT, 84132, USA., Romero CO; Department of Neurobiology, University of Utah, Salt Lake City, UT, 84132, USA., Lopez NN; Department of Neurobiology, University of Utah, Salt Lake City, UT, 84132, USA., Millar JC; Department of Pharmacology and Neuroscience and North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA., Vetter ML; Department of Neurobiology, University of Utah, Salt Lake City, UT, 84132, USA., Bosco A; Department of Neurobiology, University of Utah, Salt Lake City, UT, 84132, USA. Electronic address: alejandra.bosco@neuro.utah.edu.
Publikováno v:
Experimental eye research [Exp Eye Res] 2024 Nov; Vol. 248, pp. 110114. Date of Electronic Publication: 2024 Oct 03.
Autor:
Lazovic B; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland., Nguyen HT; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.; Finnadvance Ltd., Oulu, Finland., Ansarizadeh M; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland., Wigge L; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Kohl F; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Li S; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Carracedo M; Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Kettunen J; Finnadvance Ltd., Oulu, Finland., Krimpenfort L; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Elgendy R; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Richter K; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland., De Silva L; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland., Bilican B; Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Singh P; Finnadvance Ltd., Oulu, Finland., Saxena P; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jakobsson L; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Hong X; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Eklund L; Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland., Hicks R; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. ryan.hicks@astrazeneca.com.; School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK. ryan.hicks@astrazeneca.com.
Publikováno v:
Angiogenesis [Angiogenesis] 2024 Aug; Vol. 27 (3), pp. 523-542. Date of Electronic Publication: 2024 May 21.
Autor:
Carucci M; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK. caruccim@cardiff.ac.uk., Clamp A; The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK., Zhou C; Cancer Research National Biomarker Centre, The University of Manchester, Manchester, UK., Hurt C; University of Southampton, Southampton, UK., Glasspool R; Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK., Monaghan PJ; The Christie Pathology Partnership, Manchester, UK., Thirkettle S; The Christie Pathology Partnership, Manchester, UK., Wheatley M; The Christie Pathology Partnership, Manchester, UK., Mahmood M; The Christie Pathology Partnership, Manchester, UK., Narasimham M; The University of Manchester, Manchester, UK., Cox T; The Christie NHS Foundation Trust, Manchester, UK., Morrison H; Centre for Trials Research, Cardiff University, Cardiff, UK., Campbell S; Centre for Trials Research, Cardiff University, Cardiff, UK., Nelson A; Marie Curie Research Centre, Cardiff University, Cardiff, UK., Holland-Hart D; Marie Curie Research Centre, Cardiff University, Cardiff, UK., Hopewell-Kelly N; Marie Curie Research Centre, Cardiff University, Cardiff, UK., Thomas A; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Porter C; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Slusarczyk M; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Irving A; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Dive C; Cancer Research National Biomarker Centre, The University of Manchester, Manchester, UK., Adams R; Centre for Trials Research, Cardiff University, 6thFloor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Jayson GC; The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Oct 24; Vol. 24 (1), pp. 1309. Date of Electronic Publication: 2024 Oct 24.